Nikkiso closes buyout of Baxter's renal business

Fri, 01/10/2014 - 1:14pm
Mass Device

Nikkiso America completed its deal for Baxter's continuous renal replacement therapy for treating acute kidney injury.

Nikkiso closes buyout of Baxter's renal business

Nikkiso America said it closed the buyout of Baxter's (NYSE:BAX) continuous renal replacement therapy business for an undisclosed sum.

San Diego-based Nikkiso America is the U.S. division of Japanese industrial giant Nikkiso Co. (TYO:6376). The company’s medical division is known for its blood purification and dialysis products. The CRRT product line includes the Aquarius system, a dialysis device originally manufactured by Nikkiso.

Nikkiso will now be responsible for the marketing, distribution and manufacturing of the full line of products. The company will also take on the 85 employees that are connected with the CRRT product line.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.